Canadian Cancer Trials Group Bulletins

General


News: Story on BWEL study (Alliance: A011401) (CCTG: MAC.20)

The Canadian Clinical Trials Group (CCTG) will be the Canadian arm of this international study BWEL led by a US group, the Alliance. The trial is not open accrual yet.

BWEL (Alliance: A011401) (CCTG: MAC.20) is the first study to test whether losing weight through reducing calories and exercising can lower the risk of breast cancer recurrence. This study will evaluate the role of weight loss in overweight (BMI >=27 kg/m^2) women with early breast cancer. Participants will have been diagnosed with invasive breast cancer within the past 12 months and completed all their chemotherapy, radiation and surgery before starting the study.

Read more here: http://www.onclive.com/web-exclusives/weight-loss-program-aims-to-pinpoint-role-of-obesity-in-breast-cancer?p=: